Stockscreener 앱 받기
0.70
2.94%
0.02
전일 마감가:
$0.68
열려 있는:
$0.687
하루 거래량:
35,265
Relative Volume:
0.03
시가총액:
$22.92M
수익:
$1.13M
순이익/손실:
$-20.74M
주가수익비율:
-0.7955
EPS:
-0.88
순현금흐름:
$-18.37M
1주 성능:
+0.00%
1개월 성능:
-23.06%
6개월 성능:
-1.41%
1년 성능:
-52.05%
1일 변동 폭
$0.6465
$0.70
1주일 범위
$0.616
$0.73
52주 변동 폭
$0.55
$1.79
Cyclo Therapeutics Inc Stock (CYTH) Company Profile
명칭
Cyclo Therapeutics Inc
전화
386-418-8060
주소
6714 NW 16TH STREET, SUITE B, GAINESVILLE
CYTH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CYTH
Cyclo Therapeutics Inc
|
0.70 | 22.92M | 1.13M | -20.74M | -18.37M | -0.88 |
|
ZTS
Zoetis Inc
|
163.03 | 73.00B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.19 | 47.99B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.28 | 46.48B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.10 | 18.45B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
131.65 | 14.00B | 612.78M | -86.37M | -62.91M | -0.87 |
Cyclo Therapeutics Inc 주식(CYTH)의 최신 뉴스
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Cyclo Therapeutics Announces Allowance of Patent Application for Treatment of Alzheimer’s Disease from the U.S. Patent and Trademark Office - Business Wire
CYCLO THERAPEUTICS Earnings Preview: Recent $CYTH Insider Trading, Hedge Fund Activity, and More - Nasdaq
Rafael Holdings Inc Reports Q2 2025 Earnings: EPS at -$0.19, Str - GuruFocus.com
Rafael Holdings, Inc. SEC 10-Q Report - TradingView
Rafael Holdings Reports Second Quarter Fiscal 2025 Financial Results - The Manila Times
Rafael Holdings, Inc. Reports Financial Results and Anticipates Closure of Merger with Cyclo Therapeutics in Q3 - Nasdaq
Rafael Holdings Reports Second Quarter Fiscal 2025 Financial Results - GlobeNewswire Inc.
Cyclo Therapeutics (CYTH) to Release Quarterly Earnings on Monday - Defense World
Cyclo Therapeutics secures $2.5 million in funding By Investing.com - Investing.com Australia
Is Cyclo Therapeutics, Inc. (CYTH) the Best Micro Cap Stock to Buy Now? - Insider Monkey
10 Best Micro Cap Stocks to Buy Now - Insider Monkey
Cyclo Therapeutics Inc Issues $2.5 Million Convertible Promissory Note To Rafael Holdings - Marketscreener.com
Cyclo Therapeutics secures $2.5 million in funding - Investing.com India
Emerging Market ETFs: A Shield Against Trump’s Tariff Threats? - The Globe and Mail
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BLUE, VOXX, CARA, CYTH on Behalf of Shareholders - The Malaysian Reserve
CYCLO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cyclo Therapeutics, Inc.CYTH - Business Wire
Emera Inc (EMA:CA) Stock Analysis: Q4 2024 Earnings & Forecast - The Globe and Mail
Cyclo Therapeutics extends merger agreement with Rafael Holdings - MSN
Reviewing Cyclo Therapeutics (NASDAQ:CYTH) and Vitro Diagnostics (OTCMKTS:VODG) - Defense World
Cyclo Therapeutics Inc (CYTH) Stock: A Year of Market Movement, Down and Up - The InvestChronicle
Adversity is less terrifying than hope: Cyclo Therapeutics Inc (CYTH) - SETE News
Rafael Holdings Extends Merger Agreement Deadline By Investing.com - Investing.com Australia
Rafael Holdings Extends Merger Agreement Deadline - MSN
Cyclo Therapeutics logs efficacy win in pivotal Niemann-Pick disease trial - Clinical Trials Arena
Conduit, MGO Global, and Cyclo Therapeutics: Penny Stocks to Watch This Week - PUNE.NEWS
Tilray Brands (TLRY) Stock Dips Amid Market Volatility - GuruFocus.com
3 Penny Stocks to Watch Now, 2/11/25 - TipRanks
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Will Cyclo Therapeutics Inc (CYTH) meet earnings estimates this quarter? - US Post News
Investing in Rigetti Computing Inc (RGTI) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News
Cyclo Therapeutics reports promising NPC1 treatment findings - MSN
Clinical Trials News Live Feed - StockTitan
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CYTH, VGR, TTNP on Behalf of Shareholders - ACCESS Newswire
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Cyclo Therapeutics Inc’s: Contrasting Stock Performances in a Volatile Market - The InvestChronicle
Is Lipella Pharmaceuticals Inc (NASDAQ:LIPO) stock a better investment at this time? - US Post News
What will the future hold for Apple Inc (NASDAQ:AAPL) stock? - US Post News
Cyclo Therapeutics Inc (NASDAQ:CYTH) stock: You might be surprised - US Post News
Cyclo Therapeutics Presents Positive Data From Phase 3 NPC1 Sub-Study - Nasdaq
Artificial Intelligence (AI) News Live Feed - StockTitan
SolarWinds Corp (SWI) Stock Price and Analyst Predictions - The News Heater
Analyzing the Price-to-Earnings Ratio of Cyclo Therapeutics Inc (CYTH) - The News Heater
Stock market today: Garden Stage skyrocketed by 126.15% while Nikola Corporation plunged by 40.19% in early trading - Business Upturn
FNB’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
Cyclo Therapeutics reports promising NPC1 treatment findings By Investing.com - Investing.com South Africa
Cyclo Therapeutics Presents Positive Preliminary Data from Ongoing Phase 3 TransportNPC(TM) Open-Label Sub-Study in Patients ( - Marketscreener.com
Cyclo Therapeutics Inc (CYTH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.47%
2.00%
자본화:
|
볼륨(24시간):